European Archives - Page 605 of 1121 - European Medical Journal

In Memory of Professor Donal O’Donoghue OBE

We fondly remember respected nephrologist, researcher, and our EMJ Nephrology editorial board member Prof Donal O’Donoghue.

The 2021 pharma forecast

Looking forward to the year ahead, GOLD casts five predictions for what the standout advancements and priorities will be for pharma in 2021.

EMJ Oncology 9 [Supplement 1] 2021 feature image

EMJ Oncology 9 [Supplement 1] 2021

FOUR leading experts in the field of oncology were brought together in an interview to discuss the epidemiology, treatment decisions…

EMJ Oncology 9 [Supplement 1] 2021 feature image

Expanding Possibilities in EGFR-Mutated Advanced NSCLC: Interviews with Four Key Opinion Leaders

Worldwide, there were approximately 2.10 million patients diagnosed with, and 1.77 million deaths caused by, lung cancer in 2018. Approximately…

Identifying Early Extraperitoneal High-Volume Urine Leak Post Kidney Transplantation

The first few days after kidney transplantation are the most critical in determining the fate of the graft and the recipient…

EMJ Podcast: Considering Cannabis

Jonathan sits down with Professor Michael Barnes, Chief Medical Officer, Lyphe Group and Director, Maple Tree Consultancy, to explore the subject of medicinal cannabis.

Can the Skin Predict Development of Heart Disease?

PERSONALISED precision medicine is expanding into predictive capabilities, as researchers from Thomas Jefferson University, Philadelphia, Pennsylvania…

Atopic Dermatitis and Risk of Autoimmune Disease

COMORBID autoimmune disease has been linked to diagnosis with atopic dermatitis in patients over 15 years. Case control study data from Sweden…

Plato and a Platypus walk into a bar

Jonathan Sackier discusses the role of ethics in medical practice. Jonathan will take us through the basis for ethical thinking, touch on the different types of ethics and related concepts, and discuss how ethics is viewed in other human pursuits and professions.

EMJ Cardiology 8 [Supplement 4] 2020 Feature Image

Long-Term Benefits of a Holistic Approach on Dyslipidaemia Management

Prof Banach explained that current lipid-lowering therapy (LLT) with statins, ezetimibe, and proprotein convertase subtilisin/kexin Type 9 inhibitors…